Adedoyin Olanrewaju, Frank Rachel, Vento Suzanne, Vergara Marcela, Gauthier Bernard, Trachtman Howard
Division of Nephrology, Schneider Children's Hospital of the North Shore-Long Island Jewish Health System, Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, NY 11040-1432, USA.
Pediatr Transplant. 2003 Dec;7(6):479-83. doi: 10.1046/j.1397-3142.2003.00109.x.
Pediatric patients who receive a kidney transplant require extended follow-up to monitor graft function and for management of complications. Because of convenience, most patients are sent back to the nephrologists who referred them for transplantation (the primary nephrologist) for long-term care. As a consequence, many pediatric nephrologists who provide this extended care are not associated with a transplant center. It is not known if this arrangement yields satisfactory outcomes for children and adolescents who receive a kidney transplant. The objective was to determine if clinical outcomes are satisfactory in pediatric renal transplant recipients who were followed up by their primary nephrologists after the procedure. A chart review was carried out on all renal transplant recipients seen in the renal clinic at Schneider Children's Hospital (SCH) from 1982 to 2001. Patients were eligible if they were followed up by the primary referring nephrologists at SCH for a minimum of 6 months after transplantation. Relevant demographic and clinical outcome data were compiled. Twenty-eight patients who received a total of 33 renal allografts [living related donors (LRD) 15 and cadaveric donors (CD) 18] were seen during the study period. The transplantations in 19 children (68%) were carried out at Montefiore Hospital (Bronx, NY, USA), while the rest were performed at other centers. There were three (11%) deaths, two LRD patients and one CD patient. The group of 25 surviving patients consisted of 17 males and eight females, age range 4-28 yr (mean 17.2 yr). The mean duration of renal allograft survival was 6.3 +/- 5.3 yr and the mean duration of follow-up was 6.1 +/- 5.3 yr. The most recent serum creatinine ranged from 0.5 to 3.8 mg/dL with a mean of 1.3 +/- 0.8 mg/dL. There were several complications including acute rejection, renal artery stenosis, and hydronephrosis in the allograft. The team of primary referring nephrologists successfully treated all of these except the child with hydronephrosis. The primary nephrologist who refers pediatric patients to a tertiary care transplant center can accomplish long-term follow-up of renal transplant recipients after discharge from the transplant center. The clinical outcomes are acceptable and compare favorably with the results described in the literature that have been achieved in patients followed up at transplant centers. Problems rarely developed that required referral back to the transplant center for management. This approach to care is recommended because it is more likely to foster compliance by both patients and parents.
接受肾移植的儿科患者需要长期随访,以监测移植肾功能并处理并发症。出于便利考虑,大多数患者被送回将他们转诊至移植科室的肾脏病医生(初级肾脏病医生)处接受长期护理。因此,许多提供这种长期护理的儿科肾脏病医生并未与移植中心有合作关系。对于接受肾移植的儿童和青少年而言,这种安排是否能产生令人满意的结果尚不清楚。本研究的目的是确定肾移植术后由其初级肾脏病医生进行随访的儿科肾移植受者的临床结局是否令人满意。对1982年至2001年期间在施耐德儿童医院(SCH)肾脏科就诊的所有肾移植受者进行了病历回顾。如果患者在移植后由SCH的初级转诊肾脏病医生随访至少6个月,则符合入选标准。收集了相关的人口统计学和临床结局数据。在研究期间,共观察到28例接受了33次同种异体肾移植的患者[活体亲属供者(LRD)15例,尸体供者(CD)18例]。19名儿童(68%)的移植手术在美国纽约州布朗克斯区的蒙特菲奥里医院进行,其余患者在其他中心接受移植。有3例(11%)死亡,2例为LRD患者,1例为CD患者。25名存活患者中,男性17例,女性8例,年龄范围4至28岁(平均17.2岁)。同种异体肾移植的平均存活时间为6.3±5.3年,平均随访时间为6.1±5.3年。最近一次血清肌酐水平在0.5至3.8mg/dL之间,平均为1.3±0.8mg/dL。出现了多种并发症,包括急性排斥反应、肾动脉狭窄和移植肾积水。除了肾积水患儿外,初级转诊肾脏病医生团队成功治疗了所有这些并发症。将儿科患者转诊至三级医疗移植中心的初级肾脏病医生可以在患者从移植中心出院后完成对肾移植受者的长期随访。临床结局是可以接受的,与文献中报道的在移植中心随访患者所取得的结果相比具有优势。很少出现需要转回移植中心处理的问题。推荐这种护理方式,因为它更有可能促进患者及其父母的依从性。